Last ¥1,585 JPY
Change Today +42.00 / 2.72%
Volume 798.6K
As of 1:00 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

rohto pharmaceutical co ltd (4527) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/31/14 - ¥1,872
52 Week Low
09/18/14 - ¥1,341
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ROHTO PHARMACEUTICAL CO LTD (4527)

Related News

No related news articles were found.

rohto pharmaceutical co ltd (4527) Related Businessweek News

No Related Businessweek News Found

rohto pharmaceutical co ltd (4527) Details

ROHTO Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods in Japan and internationally. The company’s eye care products comprise eye drops, eye wash preparations, and contact lens care products; and skin care products include dermal medicines, lip care, and hand/body/sun/acne care products, as well as other skin care products, such as deodorant liquid sprays, deoseptic lotions, and essences. Its internal use medicines comprise Pansiron brand medicines for overdrinking, nausea, vomiting, stomach discomfort, over-eating, indigestion, promotion of digestion, dyspepsia, heartburn, stomach pain, hyperacidity, belching, heaviness in the stomach/chest, and feeling of fullness in the stomach and abdomen. The company’s internal use medicines also include cold remedies for cold symptoms and antitussive syrups; other internal medicines for rest, constipation, cold, nasal discharge, and sneezing; supplements for body, skin, and blood sugar levels, as well as for fat diet and daily meals; and other internal use medicines for clean intestine environment. In addition, it offers test kits, such as OTC pregnancy and diagnostic test kits; Hay fever products for the treatment of stuffy or runny nose due to allergic rhinitis; and denture cleanser products for daily sanitation of dentures and mouth, and nicotine or tar stains. The company was formerly known as Yamada Pharmaceutical and changed its name to ROHTO Pharmaceutical Co., Ltd. in 1949. ROHTO Pharmaceutical Co., Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

5,845 Employees
Last Reported Date: 06/25/14
Founded in 1899

rohto pharmaceutical co ltd (4527) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rohto pharmaceutical co ltd (4527) Key Developments

Rohto Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Aug 07, 2014

Rohto Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Aug 07, 2014

Rohto Pharmaceutical Co., Ltd. to Report Q2, 2015 Results on Nov 11, 2014

Rohto Pharmaceutical Co., Ltd. announced that they will report Q2, 2015 results on Nov 11, 2014

Rohto Pharmaceutical Co., Ltd., Q2 2015 Earnings Call, Nov 14, 2014

Rohto Pharmaceutical Co., Ltd., Q2 2015 Earnings Call, Nov 14, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4527:JP ¥1,585.00 JPY +42.00

4527 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4527.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4527 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROHTO PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at